Torben Barington

Torben Barington is a Clinical Professor at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, and a Consultant at the Department of Clinical Immunology, Odense University Hospital. He has held this position since August 2001 and continues to be actively involved in research, teaching, and clinical leadership.

• MD, University of Copenhagen, 1987
• Doctoral Thesis (dr.med.), University of Copenhagen, 1996
• Specialist in Clinical Immunology, 1998

His research focuses on cellular immunotherapy of cancer, particularly using CAR T-cell and CAR NK-cell technologies, primary immunodeficiencies, and the B-lymphocyte repertoire and immunoglobulin genes. His work bridges fundamental immunology with clinical applications in oncology and immunodeficiency disorders.

His recent publications (2024–2025) highlight advancements in CAR T/NK-cell characterization, cytotoxicity assays, clinical translation, and tumor microenvironment interactions. These works reflect a strong trend toward translational immunology, with emphasis on personalized cancer therapy, single-cell technologies, and clinical trial development.

Scientific Awards:

• Aage og Edith Dyssegaards Fonds æreslegat (1993)
• Silver Medal, University of Copenhagen (1981)

He has supervised over 30 thesis students and currently mentors several graduate students in CAR-based cancer immunotherapies. He serves as an examiner for PhD defenses at both the University of Southern Denmark and the University of Copenhagen. He is also actively involved in national scientific leadership, including as Chairman of the Scientific Committee of the Danish Blood Donor Organization since 2011 and as a member of the Advisory Board for Clinical Immunology in the Region of Southern Denmark since 2007.

His research is conducted in collaboration with multidisciplinary teams focusing on cellular immunotherapy, clinical immunology, and translational hematology, often in partnership with Odense University Hospital and national blood and immunology networks.